AROSIO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 4.943
AS - Asia 2.699
EU - Europa 2.541
SA - Sud America 365
AF - Africa 64
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.624
Nazione #
US - Stati Uniti d'America 4.634
SG - Singapore 980
CN - Cina 630
IT - Italia 610
VN - Vietnam 349
DE - Germania 325
RU - Federazione Russa 310
BR - Brasile 292
HK - Hong Kong 269
CA - Canada 265
SE - Svezia 257
GB - Regno Unito 186
IE - Irlanda 184
UA - Ucraina 129
IN - India 121
FR - Francia 119
AT - Austria 90
PL - Polonia 89
FI - Finlandia 78
TR - Turchia 51
BD - Bangladesh 46
JP - Giappone 40
KR - Corea 40
ES - Italia 34
DK - Danimarca 31
BE - Belgio 30
IQ - Iraq 30
NL - Olanda 30
MX - Messico 26
AR - Argentina 25
ID - Indonesia 25
PK - Pakistan 19
ZA - Sudafrica 19
PH - Filippine 17
EG - Egitto 14
IR - Iran 14
EC - Ecuador 13
CO - Colombia 12
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
SA - Arabia Saudita 8
MA - Marocco 7
JM - Giamaica 6
JO - Giordania 6
LT - Lituania 6
TW - Taiwan 6
VE - Venezuela 6
AU - Australia 5
CL - Cile 5
KE - Kenya 5
MY - Malesia 5
RO - Romania 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
IL - Israele 4
KZ - Kazakistan 4
PT - Portogallo 4
PY - Paraguay 4
CR - Costa Rica 3
HN - Honduras 3
LB - Libano 3
LY - Libia 3
NP - Nepal 3
PE - Perù 3
TN - Tunisia 3
AL - Albania 2
BO - Bolivia 2
EU - Europa 2
GR - Grecia 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
MT - Malta 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 10.616
Città #
Ann Arbor 791
Singapore 608
Ashburn 427
Houston 305
Chandler 266
Hong Kong 257
Woodbridge 254
San Jose 250
Milan 231
Frankfurt am Main 180
Toronto 176
Dublin 174
Jacksonville 166
Dearborn 155
Wilmington 154
New York 141
Fairfield 133
Santa Clara 112
Ho Chi Minh City 109
Beijing 97
Los Angeles 91
Vienna 85
Dallas 76
Princeton 72
Hanoi 70
Kraków 65
Nanjing 62
Shanghai 58
Seattle 54
The Dalles 52
Chicago 48
Cambridge 45
Rome 33
Buffalo 32
Lachine 32
Pisa 32
São Paulo 32
Lauterbourg 31
Brussels 30
Boardman 28
Munich 27
Seoul 27
Council Bluffs 26
Guangzhou 25
Lecco 24
Shenyang 24
Moscow 23
Orem 23
Da Nang 22
Tokyo 22
Dong Ket 21
Helsinki 21
London 21
Fremont 20
Chennai 17
Ottawa 17
Pune 17
Tianjin 17
Brooklyn 16
Changsha 16
Turku 16
Atlanta 15
Jakarta 15
Manchester 15
Nanchang 15
Warsaw 15
Basingstoke 14
Phoenix 14
San Francisco 14
Amsterdam 13
Haiphong 13
Jinan 13
Montreal 13
Zhengzhou 13
Andover 12
Denver 12
Hebei 12
Lawrence 12
Stockholm 11
Altamura 10
Baghdad 10
Edmonton 10
Falls Church 10
San Diego 10
Lappeenranta 9
Ankara 8
Belo Horizonte 8
Campinas 8
Hefei 8
Johannesburg 8
Newark 8
Poplar 8
Rio de Janeiro 8
Washington 8
Cagliari 7
Hải Dương 7
Jiaxing 7
Lahore 7
Minya 7
New Delhi 7
Totale 6.870
Nome #
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 496
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 482
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis 384
Micrornas in als: from molecular mechanisms to clinical relevance 371
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 368
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 365
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 355
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 348
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 336
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 331
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 326
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 319
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 315
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 313
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 312
Alterede miRNA in Amyotrophic Lateral Sclerosis: Searching for the Lowest Common Multiple 311
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 308
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 307
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 292
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 285
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 284
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 281
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 272
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 269
BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis 264
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 259
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 251
the MonzALS collaborative network 250
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 250
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 246
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 241
Study of transcriptional alterations in Amyotrophic Lateral Sclerosis 240
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 221
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 218
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 201
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity 195
Totale 10.866
Categoria #
all - tutte 30.623
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.623


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022413 29 65 45 27 31 30 14 39 25 18 35 55
2022/2023894 71 250 76 114 68 138 7 56 69 6 18 21
2023/2024614 29 26 16 23 77 188 100 27 20 17 11 80
2024/20251.421 75 172 131 47 123 57 51 65 172 239 122 167
2025/20263.987 445 139 263 434 529 223 563 156 358 358 288 231
2026/202718 18 0 0 0 0 0 0 0 0 0 0 0
Totale 10.866